Stocks
Gossamer Bio (GOSS) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -186.1 | -234.0 | -209.3 | -211.1 | -172.2 | -62.6 | ||
| Changes by years, y/y, % | +92% | +26% | -11% | +1% | -18% | +12.2% | |||
Gossamer Bio. EBITDA US GAAP, bln rub
Gossamer Bio. EBITDA US GAAP, changes, %
Gossamer Bio. EBITDA US GAAP, sum by quarters, bln rub
Gossamer Bio (GOSS) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -35.6 | -43.9 | -37.8 | 53.1 | -33.9 | -62.6 | |
| Changes by years, y/y, % | -35% | -16% | -17% | -240% | -5% | |||
| Changes by quarters, q/q, % | -6% | +23% | -14% | -240% | -164% | |||
